يعرض 8,741 - 8,760 نتائج من 18,571 نتيجة بحث عن 'significant ((((we decrease) OR (((a decrease) OR (greater decrease))))) OR (mean decrease))', وقت الاستعلام: 0.61s تنقيح النتائج
  1. 8741

    The data of meta-analysis. حسب Da Huang (1306407)

    منشور في 2025
    "…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …"
  2. 8742

    Risk of bias. حسب Da Huang (1306407)

    منشور في 2025
    "…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …"
  3. 8743

    Overall risk of bias assessment. حسب Da Huang (1306407)

    منشور في 2025
    "…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …"
  4. 8744

    Funnel plot of VO<sub>2Peak</sub> inclusion studies. حسب Da Huang (1306407)

    منشور في 2025
    "…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …"
  5. 8745

    Analysis of subgroups. حسب Da Huang (1306407)

    منشور في 2025
    "…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …"
  6. 8746

    Multiple comparisons after ANOVA(CR10). حسب Xinyu Dai (5100731)

    منشور في 2025
    "…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …"
  7. 8747

    Homogeneity test of CR10. حسب Xinyu Dai (5100731)

    منشور في 2025
    "…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …"
  8. 8748

    Illustration of the fNIRS device worn. حسب Xinyu Dai (5100731)

    منشور في 2025
    "…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …"
  9. 8749

    Analysis of variance of HbO<sub>2</sub> in bilateral PFC. حسب Xinyu Dai (5100731)

    منشور في 2025
    "…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …"
  10. 8750

    fNIRS equipment coordinates. حسب Xinyu Dai (5100731)

    منشور في 2025
    "…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …"
  11. 8751

    Changes of muscle oxygen saturation. حسب Xinyu Dai (5100731)

    منشور في 2025
    "…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …"
  12. 8752

    Analysis of variance of CR10. حسب Xinyu Dai (5100731)

    منشور في 2025
    "…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …"
  13. 8753

    Placement on the forehead. حسب Xinyu Dai (5100731)

    منشور في 2025
    "…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …"
  14. 8754

    IMW intervention plan design. حسب Xinyu Dai (5100731)

    منشور في 2025
    "…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …"
  15. 8755
  16. 8756

    Table 1_Factors affecting health-seeking behavior in sports climbers in Metro Manila: a cross-sectional study.docx حسب Danyelle Jay T. Cruz (20772668)

    منشور في 2025
    "…Among the injury factors studied, the location of pain at the hip/pelvis and knee was found to be significant (p < 0.05).</p>Discussion<p>Climbers in Metro Manila have a decreased tendency to engage in health-seeking behavior. …"
  17. 8757

    Data Sheet 1_Efficacy and safety of different medications compared for the treatment of postherpetic neuralgia: a network meta-analysis.pdf حسب Zhen Guo (68566)

    منشور في 2025
    "…The secondary outcomes showed a significant effect of hydromorphone in improving sleep quality (MD = −3.8, 95% CI: [−23.0, −15.0]) and decreasing pain questionnaire scores (MD = −13.0, 95% CI: [−28.0, 2.1]). …"
  18. 8758

    Data Sheet 6_Efficacy and safety of different medications compared for the treatment of postherpetic neuralgia: a network meta-analysis.pdf حسب Zhen Guo (68566)

    منشور في 2025
    "…The secondary outcomes showed a significant effect of hydromorphone in improving sleep quality (MD = −3.8, 95% CI: [−23.0, −15.0]) and decreasing pain questionnaire scores (MD = −13.0, 95% CI: [−28.0, 2.1]). …"
  19. 8759

    Data Sheet 3_Efficacy and safety of different medications compared for the treatment of postherpetic neuralgia: a network meta-analysis.pdf حسب Zhen Guo (68566)

    منشور في 2025
    "…The secondary outcomes showed a significant effect of hydromorphone in improving sleep quality (MD = −3.8, 95% CI: [−23.0, −15.0]) and decreasing pain questionnaire scores (MD = −13.0, 95% CI: [−28.0, 2.1]). …"
  20. 8760

    Data Sheet 2_Efficacy and safety of different medications compared for the treatment of postherpetic neuralgia: a network meta-analysis.pdf حسب Zhen Guo (68566)

    منشور في 2025
    "…The secondary outcomes showed a significant effect of hydromorphone in improving sleep quality (MD = −3.8, 95% CI: [−23.0, −15.0]) and decreasing pain questionnaire scores (MD = −13.0, 95% CI: [−28.0, 2.1]). …"